Low-Molecular-Weight Heparin for Vertebral Artery Dissection

Abstract

A case of vertebral artery dissection and consequent basilar artery thrombosis in a 6-year-old patient is reported. The patient was treated with subcutaneous low-molecular-weight heparin at therapeutic doses (enoxaparin, 100 IU/kg twice daily) for 3 weeks, then reduced to 2,000 IU/day for 3 more weeks. After this time a magnetic resonance angiogram was obtained that showed complete recanalization of the left basilar artery. Enoxaparin proved to be a safe and useful therapy for thrombosis accompanying vertebral artery dissection.

Keywords

Low-molecular-weight heparin Vertebral artery dissection

References

1. Hart RG , Easton JD . Dissections of cervical and cerebral arteries. Neurol Clin North Am 1983;1:255-255.

2. Khurana DS , Bonnemann CG , Dooling EC , et al. Vertebral artery dissection: Issues in diagnosis and management Pediatr Neurol 1996;14:255-255.

3. Pitter JH , French JH , PeBenito R , et al. Vertebrobasilar occlusion complicating nonpenetrating cranicocervical trauma in a child. J Child Neurol 1990;5:219-219.

4. Garg BP , Ottinger CJ , Smith RR , et al. Strokes in children due to vertebral artery trauma. Neurology 1993;43:2555-2555.

5. Schievinck WI , Mokri B , Piepgras DG . Spontaneous dissections of cervicocephalic arteries in childhood and adolescence. Neurology 1994;44:1607-1607.

6. Schievinck WI , Mokri B , O'Fallon M . Recurrent spontaneous cervical artery dissection. N Engl J Med 1994;6:393-393.

7. Lyrer P , Engelter S . Antithrombotic drugs for carotid artery dissection (Cochrane review). Cochrane Database Syst Rev 2000;4:CD000255-CD000255.

8. Schievink WI . Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001;344:898-898.

9. de Brujin SFTM and Stam J for the Cerebral Venous Sinus Thrombosis Study Group . Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-484.

10.

10. Kalafut MA , Gandhi R , Kidwell CS , et al. Safety and cost of of low-molecular-weight heparin as bridging anticoagulant therapy in subacute cerebral ischemia. Stroke 2000;31 2563-2563.

11.

11. Hyers TM , Agnelli G , Hull RD , et al. Antithrombotic therapy for venous thromboembolic disease. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119:176S-176S.

12.

12. Hirsh J , Warkentin TE , Shaughnessy SG , et al. Heparin and low-molecular-weight heparin. Sixth ACCP consensus conference on antithrombotic therapy. Chest 2001;119:64S-64S.

13.

13. Strater R , Kurnik K , Heller C , et al. Aspirin versus lowmolecular-weight heparin: Antithrombotic therapy in pediatric ischemic stroke patients. A prospective follow-up study. Stroke 2001;32:2554-2554.